Safety and tolerability of omalizumab
Jonathan Corren(California Allergy and Asthma Medical Group), Pablo A. Jimenez(Ziarco (United Kingdom)), Roland Buhl(University of Applied Sciences Mainz), Thomas B. Casale(University of South Florida), Stephen T. Holgate(University of Southampton), Bob Lanier(JPS Health Network)
Cited by 253
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k
Lebrikizumab Treatment in Adults with Asthma
|New England Journal of Medicine|2011|1.5k
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
|Journal of Allergy and Clinical Immunology|2011|1.2k